E3 PreliminaryPreliminaryPEM not requiredEditorialPeer-reviewedReviewed
Pain in patients with chronic fatigue syndrome: does nitric oxide trigger central sensitisation?
Nijs, Jo, Van de Velde, Bart, De Meirleir, Kenny · Medical hypotheses · 2005 · DOI
Quick Summary
This study proposes a theory about why ME/CFS patients experience widespread pain. The researchers suggest that a molecule called nitric oxide may cause the central nervous system (the brain and spinal cord) to become overly sensitive, amplifying pain signals throughout the body. They propose that viral infections or other pathogens associated with ME/CFS may trigger this chain reaction, and that behaviors like catastrophizing or avoiding activity may either contribute to or result from this heightened sensitivity.
Why It Matters
Pain is a major driver of disability in ME/CFS, accounting for over a quarter of activity limitations. Understanding the biological mechanisms underlying widespread pain could lead to targeted treatments and help distinguish ME/CFS pain from other chronic pain conditions.
Observed Findings
- Pain severity accounts for 26-34% of variability in activity limitations and participation restrictions in CFS patients
- Deregulation of the 2',5'-oligoadenylate synthetase/RNase L pathway occurs in CFS patients
- CFS patients demonstrate behavioral patterns including catastrophizing, avoidance behavior, and somatization
Inferred Conclusions
- Nitric oxide-dependent reduction in central nervous system inhibitory activity may trigger central sensitization responsible for widespread pain in CFS
- Infectious agents associated with CFS may initiate or accelerate the proposed nitric oxide/central sensitization pathway
- Behavioral patterns in CFS patients are consistent with central sensitization mechanisms
Remaining Questions
- Does nitric oxide directly cause central sensitization in ME/CFS patients, or is this correlation indirect?
- Which infectious agents most commonly initiate this proposed pathway, and why do some exposed individuals develop ME/CFS while others do not?
- Do behavioral interventions that address catastrophizing and avoidance reduce central sensitization and pain in ME/CFS patients?
- How can this theoretical model be experimentally tested in living ME/CFS patients?
What This Study Does Not Prove
This is a theoretical hypothesis paper, not an empirical study with patient data or experimental evidence. It does not prove that nitric oxide directly causes central sensitization in ME/CFS patients, nor does it establish which direction causality flows between behavioral changes and nervous system sensitization. The proposal remains speculative and requires experimental validation.
Tags
Symptom:PainFatigue
Biomarker:Gene ExpressionBlood BiomarkerCytokines
Phenotype:Infection-Triggered
Method Flag:Exploratory OnlyWeak Case Definition
Metadata
- DOI
- 10.1016/j.mehy.2004.07.037
- PMID
- 15617866
- Review status
- Editor reviewed
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 12 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.